When people hear “AI misdiagnosis,” they often assume it was caused by a single piece of software that somehow replaced medical judgment. In practice, the situation is usually more complex. Automated tools may support clinicians by highlighting risk, suggesting likely conditions, organizing data, or assisting with imaging and lab workflows. Those tools can be helpful, but they can also contribute to harm when they are used without adequate verification or when their outputs are misunderstood.
In Hawaii, the diagnostic process may involve multiple handoffs, including referrals between facilities and specialists, and sometimes delays caused by scheduling, imaging availability, or transport. If an automated tool influenced what was considered “most likely,” or if an abnormal result was routed incorrectly, the legal question becomes whether the care team met an appropriate standard of evaluation and follow-up.
It’s also common for delays to be driven by workflow rather than a single “mistake.” For example, a patient may present with symptoms that sound nonspecific at first, while a risk-scoring tool may direct the patient toward a less urgent pathway. Later, when the condition becomes more obvious, the diagnosis may change. The legal issue is whether the earlier assessment reasonably accounted for the available information and whether abnormal findings were handled correctly.


